Abstract
In Reply. —The criticisms of Drs Szabo and Kilbourn are directed at studies indicating that NOS inhibitors are potentially harmful. They suggest that these investigations should be disregarded on the basis of various hypotheses: the dose of endotoxin was too high; the wrong sepsis model was used; the wrong NOS inhibitor was chosen; the NOS inhibitor was not administered at the right time or in the correct manner; the adverse effects were disease related and not due to NOS inhibition; or, finally, other agents were not given to reverse the untoward effects of NOS inhibition. Like the many other endogenous mediators of septic shock, nitric oxide has potential both to protect and to harm the host. Our review describes this dual nature and reflects our belief in scientific discourse founded on consideration of all results. Historically, such an approach has proven to be effective in incorporating new agents into clinical practice and
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
